Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types

HTSeq—a Python framework to work with high-throughput sequencing data

Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660

Primer3—new capabilities and interfaces

Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C., Remm, M., & Rozen, S. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks596 · Cited by 9,461

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056

Integrated genomic characterization of endometrial carcinoma

The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461

The Somatic Genomic Landscape of Glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing

Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,905

GENCODE: The reference human genome annotation for The ENCODE Project

Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. (2012) · Genome Research · doi:10.1101/gr.135350.111 · Cited by 4,585

Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test

Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,356

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278

Highly Recurrent TERT Promoter Mutations in Human Melanoma

Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816

TERT Promoter Mutations in Familial and Sporadic Melanoma

Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799

Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor

McLaren, W., Pritchard, B., Rios, D., Chen, Y., Flicek, P., & Cunningham, F. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq330 · Cited by 1,586

Methods for Detecting Associations with Rare Variants for Common Diseases: Application to Analysis of Sequence Data

Li, B., & Leal, S. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.06.024 · Cited by 1,527

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368

Lessons from the Cancer Genome

Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308

Cis-regulatory elements: Molecular mechanisms and evolutionary processes underlying divergence

Wittkopp, P. J., & Kalay, G. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3095 · Cited by 1,231

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105

Alternative lengthening of telomeres: models, mechanisms and implications

Cesare, A. J., & Reddel, R. R. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2763 · Cited by 1,035

Frequency of TERT promoter mutations in human cancers

Vinagre, J., Almeida, A., Pópulo, H., Batista, R., Lyra, J., Pinto, V., Coelho, R., Celestino, R., Prazeres, H., Lima, L., et al. (2013) · Nature Communications · doi:10.1038/ncomms3185 · Cited by 898

Genome-wide association study identifies five susceptibility loci for glioma

Shete, S., Hosking, F. J., Robertson, L. B., Dobbins, S. E., Sanson, M., Malmer, B., Simon, M., Marie, Y., Boisselier, B., Delattre, J.-Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.407 · Cited by 788

Melanoma genome sequencing reveals frequent PREX2 mutations

Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756

Evolution of the cancer genome

Yates, L. R., & Campbell, P. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3317 · Cited by 640

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

Liu, X., Bishop, J., Shan, Y., Pai, S., Liu, D., Murugan, A. K., Sun, H., El-Naggar, A. K., & Xing, M. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0210 · Cited by 613

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

Rafnar, T., Sulem, P., Stacey, S. N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K. K. H., et al. (2009) · Nature Genetics · doi:10.1038/ng.296 · Cited by 609

TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL

Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.18 · Cited by 529

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Study, A. C., Bojesen, S. E., Study, A. O. C., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), (GENICA), G. E. I. A. B. C., (SWE-BRCA), S. B. C. S., The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), (EMBRACE), E. S. O. B. &. B. M. C., (GEMO), G. M. O. C. R. I. B. M. C., Pooley, K. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2566 · Cited by 528

Emerging patterns of somatic mutations in cancer

Watson, I. R., Takahashi, K., Futreal, P. A., & Chin, L. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3539 · Cited by 491

Genome-wide analysis of noncoding regulatory mutations in cancer

Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484

Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins

Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

Rachakonda, P. S., Hosen, I., de Verdier, P. J., Fallah, M., Heidenreich, B., Ryk, C., Wiklund, N. P., Steineck, G., Schadendorf, D., Hemminki, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310522110 · Cited by 340

Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci

Li, Q., Seo, J.-H., Stranger, B., McKenna, A., Pe’er, I., LaFramboise, T., Brown, M., Tyekucheva, S., & Freedman, M. L. (2013) · Cell · doi:10.1016/j.cell.2012.12.034 · Cited by 308

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

The Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium, Haiman, C. A., Chen, G. K., Vachon, C. M., Canzian, F., Dunning, A., Millikan, R. C., Wang, X., Ademuyiwa, F., Ahmed, S., et al. (2011) · Nature Genetics · doi:10.1038/ng.985 · Cited by 306

Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

Allory, Y., Beukers, W., Sagrera, A., Flández, M., Marqués, M., Márquez, M., van der Keur, K. A., Dyrskjot, L., Lurkin, I., Vermeij, M., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.052 · Cited by 284

A General Framework for Detecting Disease Associations with Rare Variants in Sequencing Studies

Lin, D.-Y., & Tang, Z.-Z. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.015 · Cited by 273

Pathways and therapeutic targets in melanoma

Shtivelman, E., Davies, M. A., Hwu, P., Yang, J., Lotem, M., Oren, M., Flaherty, K. T., & Fisher, D. E. (2014) · Oncotarget · doi:10.18632/oncotarget.1892 · Cited by 217

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma

Heidenreich, B., Nagore, E., Rachakonda, P. S., Garcia-Casado, Z., Requena, C., Traves, V., Becker, J., Soufir, N., Hemminki, K., & Kumar, R. (2014) · Nature Communications · doi:10.1038/ncomms4401 · Cited by 189

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

Speedy, H. E., Di Bernardo, M. C., Sava, G. P., Dyer, M. J. S., Holroyd, A., Wang, Y., Sunter, N. J., Mansouri, L., Juliusson, G., Smedby, K. E., et al. (2014) · Nature Genetics · doi:10.1038/ng.2843 · Cited by 187

Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma

Sensi, M., Nicolini, G., Petti, C., Bersani, I., Lozupone, F., Molla, A., Vegetti, C., Nonaka, D., Mortarini, R., Parmiani, G., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209379 · Cited by 183

Identification of the Proteins Required for Biosynthesis of Diphthamide, the Target of Bacterial ADP-Ribosylating Toxins on Translation Elongation Factor 2

Liu, S., Milne, G. T., Kuremsky, J. G., Fink, G. R., & Leppla, S. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9487-9497.2004 · Cited by 168

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

Hurst, C. D., Platt, F. M., & Knowles, M. A. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.057 · Cited by 157

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

Kote‐Jarai, Z., Saunders, E. J., Leongamornlert, D. A., Tymrakiewicz, M., Dadaev, T., Jugurnauth-Little, S., Ross‐Adams, H., Olama, A. A. A., Benlloch, S., Halim, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt086 · Cited by 109

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy

Wu, R., Ayhan, A., Maeda, D., Kim, K.-R., Clarke, B. A., Shaw, P. H., Chui, M. H., Rosen, B. P., Shih, I., & Wang, T. (2013) · The Journal of Pathology · doi:10.1002/path.4315 · Cited by 103

Ovca1 regulates cell proliferation, embryonic development, and tumorigenesisPreprint

Chen, C., & Behringer, R. R. (2004) · Genes & Development · doi:10.1101/gad.1162204 · Cited by 103

Telomerase Reverse Transcriptase Gene Promoter Mutations Help Discern the Origin of Urogenital Tumors: A Genomic and Molecular Study

Wu, S., Huang, P., Li, C., Huang, Y. F., Li, X., Wang, Y., Chen, C., Lv, Z., Tang, A., Sun, X., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.10.038 · Cited by 99

Comprehensive Analysis of Long Non-Coding RNAs in Ovarian Cancer Reveals Global Patterns and Targeted DNA Amplification

Akrami, R., Skanderup, A. J., Hoell, J. I., Schultz, N. D., Sander, C., & Larsson, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080306 · Cited by 86

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas

Wang, K., Liu, T., Liu, L., Liu, J., Liu, C., Wang, C., Ge, N., Ren, H., Yan, K., Hu, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1829 · Cited by 75

CLPTM1L Promotes Growth and Enhances Aneuploidy in Pancreatic Cancer Cells

Jia, J., Bosley, A. D., Thompson, A., Hoskins, J. W., Cheuk, A., Collins, I. J., Parikh, H. M., Xiao, Z., Ylaya, K., Dzyadyk, M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3176 · Cited by 66

Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells.

Bruening, W., Prowse, A. H., Schultz, D., Holgado-Madruga, M., Wong, A. J., & Godwin, A. K. (1999) · PubMed · Cited by 62

Silencing of Diphthamide Synthesis 3 (Dph3) Reduces Metastasis of Murine Melanoma

Wang, L., Shi, Y., Ju, P., Liu, R., Yeo, S. P., Xia, Y., Owlanj, H., & Feng, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049988 · Cited by 24

OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16

Kong, F., Tong, R., Jia, L., Wei, W., Miao, X., Zhao, X., Sun, W., Yang, G., & Zhao, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0819-0 · Cited by 15

Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality

Liang, M., Ayanga, B. A., Du, S., Godwin, A. K., Hartsock, J. K., & Evans, S. C. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20535 · Cited by 9

Pan-cancer analysis of whole genomes

The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064

Universal Patterns of Selection in Cancer and Somatic Tissues

Martincorena, I., Raine, K. M., Gerstung, M., Dawson, K. J., Haase, K., Van Loo, P., Davies, H., Stratton, M. R., & Campbell, P. J. (2017) · Cell · doi:10.1016/j.cell.2017.09.042 · Cited by 1,523

Somatic mutation in cancer and normal cells

Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396

Telomeres: history, health, and hallmarks of aging

Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637

Epidemiology of Glioblastoma Multiforme–Literature Review

Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska-Bosiacka, I. (2022) · Cancers · doi:10.3390/cancers14102412 · Cited by 630